Connect with us

ThePenBuzzNews

Vaccine for major common cold virus could be ready for use by 2024


Health

Vaccine for major common cold virus could be ready for use by 2024

Health 11 August 2020 By Alice Klein Respiratory syncytial virus particles (blue) in human lung cellsNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH / SCIENCE PHOTO LIBRARY A vaccine that protects against one of the main common cold viruses has been shown to be safe and effective in a clinical trial and could be…



Health



11 August 2020

By Alice Klein

RSV virus particles

Respiratory syncytial virus particles (blue) in human lung cells

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH / SCIENCE PHOTO LIBRARY

A vaccine that protects against one of the main common cold viruses has been shown to be safe and effective in a clinical trial and could be available by 2024.

Respiratory syncytial virus (RSV) is so contagious that more than 90 per cent of people have experienced their first infection by the age of 2. It usually causes cold symptoms but can lead to severe illness in young children and older people. Globally, around 60,000 children …

Existing subscribers, please log in with your email address to link your account access.

Paid annually by Credit Card

Inclusive of applicable taxes (VAT)

*Free gift is only available with annual subscription purchases where subscription delivery is in the United Kingdom, USA, Canada, Australia, New Zealand or Euro area

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

To Top